The importance of target specificity lies in its potential to improve treatment efficacy and reduce adverse effects. By focusing on molecular or genetic abnormalities unique to cancer cells, targeted therapies can more effectively eliminate tumors with minimal collateral damage. This approach enhances the quality of life for patients and can lead to better overall outcomes.
